TGA Approval

LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 20mg/10mL Liposome Injection concentrate glass vial (202826)

ARTG ID

202826

ARTG Name

LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 20mg/10mL Liposome Injection concentrate glass vial

Sponsor

Sun Pharma ANZ Pty Ltd

ARTG Date

December 11, 2013

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Sun Pharma ANZ Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/3458e12c073249339288653f86fc3f70.pdf

https://medical-cdn.nocode.com/drug_tga/8997476f89fa3e35f1735824cd95180e.pdf

Ingredient Name

doxorubicin hydrochloride

Empowering clinical research with data-driven insights and AI-powered tools.

LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 20mg/10mL Liposome Injection concentrate glass vial (202826) - TGA 批准文号 | MedPath